Microarray-Based Cancer Prediction Using Soft Computing Approach
暂无分享,去创建一个
[1] Anthony K. H. Tung,et al. Mining top-K covering rule groups for gene expression data , 2005, SIGMOD '05.
[2] Hugo Sousa,et al. Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. , 2006, European journal of cancer.
[3] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] Koji Yamada,et al. Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor* , 2008, Journal of Biological Chemistry.
[5] Hideyuki Sakurai,et al. Pretreatment evaluation of combined HIF‐1α, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer , 2004, International journal of cancer.
[6] S. Lipkowitz,et al. A comparative structural characterization of the human NSCL-1 and NSCL-2 genes. Two basic helix-loop-helix genes expressed in the developing nervous system. , 1992, The Journal of biological chemistry.
[7] L. Hood,et al. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. , 1998, Cancer research.
[8] Bo Wang,et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. , 2008, Cancer letters.
[9] Giacomo Finocchiaro,et al. Lap2α Expression is Controlled by E2F and Deregulated in Various Human Tumors , 2006 .
[10] C. Dabrosin,et al. Estradiol Increases IL-8 Secretion of Normal Human Breast Tissue and Breast Cancer In Vivo1 , 2009, The Journal of Immunology.
[11] Sophie Lambert-Lacroix,et al. Effective dimension reduction methods for tumor classification using gene expression data , 2003, Bioinform..
[12] R Anbazhagan,et al. Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[13] S. Fan,et al. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma , 2006, The Journal of pathology.
[14] Scott A. Busby,et al. HDM2-binding partners: interaction with translation elongation factor EF1alpha. , 2007, Journal of proteome research.
[15] M Lockley,et al. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. , 2005, Experimental cell research.
[16] Daniel Birnbaum,et al. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin , 2008, BMC Cancer.
[17] Sushmita Mitra,et al. Evolutionary Rough Feature Selection in Gene Expression Data , 2007, IEEE Transactions on Systems, Man, and Cybernetics, Part C (Applications and Reviews).
[18] Yusuke Nakamura,et al. Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers , 2008, Clinical Cancer Research.
[19] J. Ross Quinlan,et al. Induction of Decision Trees , 1986, Machine Learning.
[20] Robert B Darnell,et al. β-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein , 1995, Cell.
[21] Myung-Haing Cho,et al. Aerosol delivery of urocanic acid–modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice , 2006, Molecular Cancer Therapeutics.
[22] Jinyan Li,et al. Identifying good diagnostic gene groups from gene expression profiles using the concept of emerging patterns. , 2002 .
[23] C. Heizmann,et al. The S100 family of EF-hand calcium-binding proteins: functions and pathology. , 1996, Trends in biochemical sciences.
[24] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[25] Lei Xu,et al. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[26] Makoto Arai,et al. Methylation Status of Genes Upregulated by Demethylating Agent 5-aza-2′-Deoxycytidine in Hepatocellular Carcinoma , 2007, Oncology.
[27] P. Schraml,et al. Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. , 1998, Cancer research.
[28] E Helene Sage,et al. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family. , 2004, The international journal of biochemistry & cell biology.
[29] Hiroyuki Nakanishi,et al. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[31] G. Giaccone,et al. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. , 2007, Experimental cell research.
[32] M. Yoshida,et al. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. , 2000, The Journal of antibiotics.
[33] Chris H. Q. Ding,et al. Minimum redundancy feature selection from microarray gene expression data , 2003, Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE Bioinformatics Conference. CSB2003.
[34] Michael Goggins,et al. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling , 2004, Oncogene.
[35] Birgit Samans,et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1 , 2004 .
[36] Michael Bacher,et al. Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma , 2003, International journal of cancer.
[37] M. Tyers,et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. , 2002, Cancer research.
[38] T E Reichert,et al. Truncated P‐cadherin is produced in oral squamous cell carcinoma , 2008, The FEBS journal.
[39] Kotaro Mizuno,et al. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer. , 2004, Oncology reports.
[40] Jiong Wu,et al. ERbeta exerts multiple stimulative effects on human breast carcinoma cells. , 2004, Oncogene.
[41] A. Sahin,et al. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion , 2005, Molecular Cancer.
[42] C. Meijer,et al. Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B‐cell lymphoma , 2006, Hematological oncology.
[43] Z. Pawlak. Rough Sets: Theoretical Aspects of Reasoning about Data , 1991 .
[44] Xin Huang,et al. Macrophage Migration Inhibitory Factor Stimulates Angiogenic Factor Expression and Correlates With Differentiation and Lymph Node Status in Patients With Esophageal Squamous Cell Carcinoma , 2005, Annals of surgery.
[45] D. Rowley,et al. Keratinocyte‐derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model , 2009, The Prostate.
[46] H E Gabbert,et al. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas , 2004, British Journal of Cancer.
[47] P. Kuo,et al. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. , 2009, Experimental cell research.
[48] N. Colburn,et al. Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion , 2006, Molecular and Cellular Biology.
[49] Tobias Schmid,et al. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. , 2008, Cancer research.
[50] J. Neefs,et al. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation , 2000, British Journal of Cancer.
[51] Michael I. Jordan,et al. Feature selection for high-dimensional genomic microarray data , 2001, ICML.
[52] Desheng Xiao,et al. Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C alpha activation and subcellular translocation of Smac in human small cell lung cancer cells. , 2008, Acta biochimica et biophysica Sinica.
[53] Hongyun Zhang,et al. Gene Selection with Rough Sets for Cancer Classification , 2007, Fourth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2007).
[54] P. Iversen,et al. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors , 2009, Leukemia.
[55] Z. Su,et al. Translational infidelity and human cancer: role of the PTI-1 oncogene. , 1999, The international journal of biochemistry & cell biology.
[56] P. Chaurand,et al. Profiling proteins from azoxymethane‐induced colon tumors at the molecular level by matrix‐assisted laser desorption/ionization mass spectrometry , 2001, Proteomics.
[57] Takashi Tsuruo,et al. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. , 2003, Cancer research.
[58] Gang Xin,et al. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro. , 2007, Pharmacological research.
[59] Martin Schostak,et al. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value , 2008, Journal of Cancer Research and Clinical Oncology.
[60] Jiong Wu,et al. ERβ exerts multiple stimulative effects on human breast carcinoma cells , 2004, Oncogene.
[61] Elizabeth Garrett-Mayer,et al. A simple two-gene prognostic model for adenocarcinoma of the lung. , 2008, The Journal of thoracic and cardiovascular surgery.
[62] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[63] Huiqing Liu,et al. Simple rules underlying gene expression profiles of more than six subtypes of acute lymphoblastic leukemia (ALL) patients , 2003, Bioinform..
[64] E. Sage,et al. SPARC and tumor growth: Where the seed meets the soil? , 2004, Journal of cellular biochemistry.
[65] Hongyun Zhang,et al. Efficient Gene Selection with Rough Sets from Gene Expression Data , 2008, RSKT.
[66] Günther Ernst,et al. Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. , 2006, International journal of oncology.
[67] G Jean Harry,et al. G-protein Pathway Suppressor 2 (GPS2) Interacts with the Regulatory Factor X4 Variant 3 (RFX4_v3) and Functions as a Transcriptional Co-activator* , 2008, Journal of Biological Chemistry.
[68] S. Raimondi,et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. , 1992, Science.
[69] Todd,et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.
[70] Ian H. Witten,et al. Data mining - practical machine learning tools and techniques, Second Edition , 2005, The Morgan Kaufmann series in data management systems.
[71] Claus W Heizmann,et al. S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.
[72] Zhaojing Meng,et al. Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility. , 2008, Cancer research.
[73] Li Ping Cheng,et al. Study of structural and electronic origin of ambergris odor of some compounds , 2009, Journal of molecular modeling.
[74] Huan Liu,et al. Redundancy based feature selection for microarray data , 2004, KDD.
[75] Giacomo Finocchiaro,et al. Lap2alpha expression is controlled by E2F and deregulated in various human tumors. , 2006, Cell cycle.
[76] Ken Chen,et al. Macrophage Migration Inhibitory Factor Promotes Colorectal Cancer , 2009, Molecular medicine.
[77] Alfredo De Lillo,et al. P-cadherin expression and survival rate in oral squamous cell carcinoma:an immunohistochemical study , 2005, BMC Cancer.
[78] B. Aronow,et al. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. , 2005, Cancer research.
[79] Harald Schmidt,et al. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells , 2007, Apoptosis.
[80] Andrei V Bakin,et al. Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-β , 2005, Oncogene.
[81] Daniel Q. Naiman,et al. Classifying Gene Expression Profiles from Pairwise mRNA Comparisons , 2004, Statistical applications in genetics and molecular biology.
[82] K. Yoshimoto,et al. Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis. , 1995, Cancer letters.
[83] Jinyan Li,et al. Identifying good diagnostic gene groups from gene expression profiles using the concept of emerging patterns , 2002, Bioinform..
[84] Jiří Knížek,et al. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma , 1999, Electrophoresis.
[85] Carmen Jerónimo,et al. P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation , 2005, Clinical Cancer Research.
[86] Christopher I Amos,et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.
[87] Kyoungsook Park,et al. A novel cervical cancer suppressor 3 (CCS‐3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis , 2006, FEBS letters.
[88] Peter Schirmacher,et al. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. , 2007, Neoplasia.
[89] S. Ramaswamy,et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. , 2002, Cancer research.
[90] T. Shuin,et al. Expression of Angiogenesis-Related Genes Regulates Different Steps in the Process of Tumor Growth and Metastasis in Human Urothelial Cell Carcinoma of the Urinary Bladder , 2008, Pathobiology.
[91] A. Bosserhoff,et al. Functional implication of truncated P-cadherin expression in malignant melanoma. , 2006, Experimental and molecular pathology.
[92] Dingfang Li,et al. Gene Selection Using Rough Set Theory , 2006, RSKT.
[93] C. V. van Noorden,et al. Promotion of colon cancer metastases in rat liver by fish oil diet is not due to reduced stroma formation , 2004, Clinical & Experimental Metastasis.
[94] S. Groshen,et al. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[95] Michael Weller,et al. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo , 2002, Nature Medicine.
[96] Elsa Fonseca,et al. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex , 2002, Virchows Archiv.
[97] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[98] Robert Kiss,et al. Prognostic Values of Galectin-3 and the Macrophage Migration Inhibitory Factor (MIF) in Human Colorectal Cancers , 2003, Modern Pathology.
[99] Zijie Sun,et al. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both β-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells , 2008, Oncogene.
[100] Usama M. Fayyad,et al. Multi-Interval Discretization of Continuous-Valued Attributes for Classification Learning , 1993, IJCAI.
[101] B. Samans,et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). , 2004, American journal of physiology. Cell physiology.
[102] Felicitas Genze,et al. Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity , 2005, Oncogene.
[103] Q Wang,et al. Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer , 2007, Oncogene.
[104] Robert C. Holte,et al. Very Simple Classification Rules Perform Well on Most Commonly Used Datasets , 1993, Machine Learning.
[105] B.F. Momin,et al. Reduct Generation and Classification of Gene Expression Data , 2006, 2006 International Conference on Hybrid Information Technology.
[106] C. Maccalman,et al. Cadherin switching in ovarian cancer progression , 2003, International journal of cancer.
[107] Suresh Mishra,et al. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. , 2006, Biochemical and biophysical research communications.
[108] G. Folkers,et al. On the Role of Thymopoietins in Cell Proliferation. Immunochemical Evidence for New Members of the Human Thymopoietin Family , 1999, Biological chemistry.
[109] Richard Simon,et al. Supervised analysis when the number of candidate features (p) greatly exceeds the number of cases (n) , 2003, SKDD.
[110] J. Meléndez-Zajgla,et al. Apoptosis induced by cAMP requires Smac/DIABLO transcriptional upregulation. , 2007, Cellular signalling.
[111] Aik Choon Tan,et al. Ensemble machine learning on gene expression data for cancer classification. , 2003, Applied bioinformatics.
[112] Fillia Makedon,et al. HykGene: a hybrid approach for selecting marker genes for phenotype classification using microarray gene expression data , 2005, Bioinform..
[113] Yadong Wang,et al. Constructing disease-specific gene networks using pair-wise relevance metric: Application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements , 2008, BMC Systems Biology.
[114] Lin Leng,et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. , 2005, Gastroenterology.